Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

AbbVie, GMI, WuXi NextCODE Form Alliance to Sequence 45,000 Irish Genomes

publication date: Jan 10, 2017
AbbVie, a startup called Genomics Medicine Ireland, and WuXi NextCODE have formed a 15-year genomic alliance that proposes to sequence 45,000 Irish genomes. AbbVie will use the data to identify novel targets along with companion diagnostics to discover improved treatments for a number of diseases. The focus will be on oncology, neuroscience and immunology, all areas of interest for AbbVie. Financial details of the agreement were not disclosed. More details....

Stock Symbol: (NYSE: ABBV)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital